Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Evoke Pharma Inc | d833032d8k.htm |
Exhibit 16.1
December 1, 2014
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Ladies and Gentlemen:
We have read Item 4.01 of Evoke Pharma, Inc.’s Form 8-K dated November 25, 2014, and are in agreement with the statements contained in the 2nd Sentence of Paragraph 2 and the statements contained in Paragraphs 3, 4 and 5 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
Yours truly,
/s/ Ernst & Young LLP
San Diego, CA